Press Releases August 7, 2026 08:30 AM

Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation

Prenetics announces Q2 2026 financial results release, enhanced earnings communication, and upcoming investor conference participation

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
PRE

Prenetics Global Limited (NASDAQ: PRE), a consumer health company and parent of AI-native wellness brand IM8, will report Q2 2026 financial results before market open on August 18, 2026. The company introduces a detailed shareholder letter and investor deck replacing the traditional press release and will host a live-stream earnings event with management on Stocktwits. Prenetics also disclosed participation in several investor conferences in August and September 2026.

Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation
PRE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Prenetics will release Q2 2026 financial results on August 18, 2026, ahead of market open.
  • The company is enhancing investor communications by replacing traditional earnings press releases with a detailed shareholder letter and investor deck.
  • Management will host a live Q&A earnings event on Stocktwits and plans participation in multiple investor conferences.
  • IM8, Prenetics' flagship wellness brand, co-founded by David Beckham, shows strong growth, contributing significantly to the company’s consumer health focus.

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham, today announced it will release financial results for the second quarter 2026 ended June 30, 2026 before market open on Tuesday, August 18, 2026.

Beginning this quarter, Prenetics is enhancing how it communicates its financial results. In place of a traditional earnings press release, the Company will publish a detailed shareholder letter and an accompanying investor deck on its investor relations website at https://ir.prenetics.com/, providing shareholders with a more comprehensive view of the Company’s performance, strategy and outlook.

The Company will also host a live-streamed earnings event on Stocktwits the same day at 8:30 a.m. Eastern Time, during which management will discuss the results and hold a Q&A session. The live-stream will be accessible at https://stocktwits.com/symbol/PRE. Investors who wish to submit questions may do so by emailing [email protected].

A replay of the live-stream will be available on the Company’s investor relations website at https://ir.prenetics.com/.

Upcoming Investor Conferences

Prenetics’ management will participate in the following upcoming conferences:

  • Canaccord Genuity’s 46th Annual Growth Conference, being held August 11-13, 2026 at the InterContinental in Boston, MA. The fireside chat will be available for viewing here and on the Company’s investor relations website.
  • Lake Street’s 10th Annual Best Ideas Growth Conference, being held Thursday, September 10, 2026 at the Metropolitan Club in New York City.
  • UBS’s Athletic Training & Lifestyle Innovation Day, being held Thursday, September 10, 2026 at the Langham, Boston in Boston, MA.
  • B. Riley’s Consumer & TMT Conference, being held Thursday, September 10, 2026 at the InterContinental New York Times Square in New York City.
  • Beanstalk 2026, being held September 14-16, 2026 at Industry City in Brooklyn, NY.

To schedule a one-on-one meeting with Prenetics’ management, please contact Investor Relations at [email protected] or your conference representative.

About Prenetics

Prenetics Global Limited (NASDAQ: PRE) is a leading consumer health company on a mission to advance human health and longevity. Its flagship brand, IM8, co-founded with David Beckham, is redefining premium daily nutrition through science-backed formulations — anchored by Daily Ultimate Essentials, a 90-ingredient daily nutrition system that is NSF Certified for Sport and clinically studied. IM8 is the fastest-growing premium supplement brand ever recorded, surpassing $200 million in annualized run-rate revenue within 18 months of launch, shipping to 46 countries, and delivering approximately 200,000 servings daily. IM8's ambassador and equity-partner roster includes David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, Jay Shetty, and Inter Miami CF. Learn more at prenetics.com and im8health.com.

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials Pro, is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com.

Investor Relations Contact:

[email protected]
[email protected]

Angela Cheung
Investor Relations / Corporate Finance
[email protected]


Risks

  • Financial results may fall short of investor expectations, affecting stock performance.
  • The effectiveness of the new investor communication approach is untested and may impact investor perceptions.
  • Market competition and regulatory challenges in consumer health and wellness sectors could affect future growth prospects.

More from Press Releases

Elevra Lithium Completes Sale of E45/2364 Pegmatite Rights Aug 7, 2026 AZIO AI Holdings Inc. (NASDAQ: AZIO) Signs Key Agreement, Establishes Focus on AI Compute Infrastructure Aug 7, 2026 Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million Aug 7, 2026 PN Smart Energy Limited Announces Pricing of $5.0 Million Registered Direct Offering Aug 7, 2026 OceanLight Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering Aug 7, 2026